Dr Reddys Laboratories RDY
NYSE RDY
$13.10 +0.03 (+0.23%)
As of: Oct 19, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Non-Current Debt (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Non-Current Debt of $150.67 million for the quarter ended Jun 30, 2026, down 24.3% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Non-Current Debt (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories posted Non-Current Debt of $130 million, up 41.3% from the prior year.

  • Non-Current Debt has a five-year compound annual growth rate of 8.6% (years ended Mar 2021 to Mar 2026).
  • By year, Non-Current Debt came in at $92 million in the year ended Mar 31, 2025 (+27.8%), $72 million in the year ended Mar 31, 2024 (-56.1%), $164 million in the year ended Mar 31, 2023 (+115.8%) and $76 million in the year ended Mar 31, 2022 (-11.6%).
  • Five-year quarterly Non-Current Debt spans a low of $15.55 million in the quarter ended Mar 31, 2023 and a high of $301 million in the quarter ended Jun 30, 2022.
  • Year over year, Non-Current Debt gained in five of the last six quarters, with growth averaging 55.9%.
  • The high point for year-over-year Non-Current Debt in five years was the quarter ended Mar 31, 2024 (growth of 364.0%); the low point was the quarter ended Mar 31, 2023 (a decline of 79.7%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $199.16 million (quarter ended Mar 31, 2026), $195.91 million (quarter ended Dec 31, 2025) and $133.42 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 37.34 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 62.48 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 23.68 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 23.83 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 60.50 Bn
10 Dr Reddys Laboratories 10.90 Bn 10.27 Bn 396.53 Mn 150.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.48 Mn
Mar 31, 2026 129.33 Mn
Dec 31, 2025 194.34 Mn
Sep 30, 2025 131.19 Mn
Jun 30, 2025 120.10 Mn
Mar 31, 2025 91.93 Mn
Dec 31, 2024 101.24 Mn
Sep 30, 2024 87.93 Mn
Jun 30, 2024 89.99 Mn
Mar 31, 2024 71.83 Mn
Dec 31, 2023 91.22 Mn
Sep 30, 2023 88.70 Mn
Jun 30, 2023 73.74 Mn
Mar 31, 2023 15.57 Mn
Dec 31, 2022 74.79 Mn
Sep 30, 2022 79.97 Mn
Jun 30, 2022 85.74 Mn
Mar 31, 2022 75.78 Mn
Dec 31, 2021 91.80 Mn
Sep 30, 2021 92.75 Mn
API Access

Dr Reddys Laboratories Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RDY&period=max&api_key=YOUR_API_KEY